Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy

Current strategies to boost anti-tumor immune response include the use of immune checkpoint inhibitors and bispecific T cell-engaging antibodies. Here the authors describe a versatile antibody immobilization nanoplatform that can be used to deliver different combinations of immunotherapeutics, showi...

Full description

Bibliographic Details
Main Authors: Cheng-Tao Jiang, Kai-Ge Chen, An Liu, Hua Huang, Ya-Nan Fan, Dong-Kun Zhao, Qian-Ni Ye, Hou-Bing Zhang, Cong-Fei Xu, Song Shen, Meng-Hua Xiong, Jin-Zhi Du, Xian-Zhu Yang, Jun Wang
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-21497-6
id doaj-df1fd3f94ada4483a1c1ec207bb754dd
record_format Article
spelling doaj-df1fd3f94ada4483a1c1ec207bb754dd2021-03-11T11:32:22ZengNature Publishing GroupNature Communications2041-17232021-03-0112111410.1038/s41467-021-21497-6Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapyCheng-Tao Jiang0Kai-Ge Chen1An Liu2Hua Huang3Ya-Nan Fan4Dong-Kun Zhao5Qian-Ni Ye6Hou-Bing Zhang7Cong-Fei Xu8Song Shen9Meng-Hua Xiong10Jin-Zhi Du11Xian-Zhu Yang12Jun Wang13School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Life Sciences, University of Science and Technology of ChinaSchool of Life Sciences, University of Science and Technology of ChinaSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International CampusCurrent strategies to boost anti-tumor immune response include the use of immune checkpoint inhibitors and bispecific T cell-engaging antibodies. Here the authors describe a versatile antibody immobilization nanoplatform that can be used to deliver different combinations of immunotherapeutics, showing therapeutic superiority in pre-clinical models.https://doi.org/10.1038/s41467-021-21497-6
collection DOAJ
language English
format Article
sources DOAJ
author Cheng-Tao Jiang
Kai-Ge Chen
An Liu
Hua Huang
Ya-Nan Fan
Dong-Kun Zhao
Qian-Ni Ye
Hou-Bing Zhang
Cong-Fei Xu
Song Shen
Meng-Hua Xiong
Jin-Zhi Du
Xian-Zhu Yang
Jun Wang
spellingShingle Cheng-Tao Jiang
Kai-Ge Chen
An Liu
Hua Huang
Ya-Nan Fan
Dong-Kun Zhao
Qian-Ni Ye
Hou-Bing Zhang
Cong-Fei Xu
Song Shen
Meng-Hua Xiong
Jin-Zhi Du
Xian-Zhu Yang
Jun Wang
Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
Nature Communications
author_facet Cheng-Tao Jiang
Kai-Ge Chen
An Liu
Hua Huang
Ya-Nan Fan
Dong-Kun Zhao
Qian-Ni Ye
Hou-Bing Zhang
Cong-Fei Xu
Song Shen
Meng-Hua Xiong
Jin-Zhi Du
Xian-Zhu Yang
Jun Wang
author_sort Cheng-Tao Jiang
title Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
title_short Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
title_full Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
title_fullStr Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
title_full_unstemmed Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
title_sort immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2021-03-01
description Current strategies to boost anti-tumor immune response include the use of immune checkpoint inhibitors and bispecific T cell-engaging antibodies. Here the authors describe a versatile antibody immobilization nanoplatform that can be used to deliver different combinations of immunotherapeutics, showing therapeutic superiority in pre-clinical models.
url https://doi.org/10.1038/s41467-021-21497-6
work_keys_str_mv AT chengtaojiang immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT kaigechen immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT anliu immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT huahuang immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT yananfan immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT dongkunzhao immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT qianniye immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT houbingzhang immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT congfeixu immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT songshen immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT menghuaxiong immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT jinzhidu immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT xianzhuyang immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
AT junwang immunomodulatingnanoadaptorspotentiateantibodybasedcancerimmunotherapy
_version_ 1724225438896619520